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Abstract
Cells are able to sense their physical surroundings through mechanotransduction.
In doing so, they can translate the mechanical forces and deformations into a wide range
of biochemical signals and genetic programs which can adjust their structure and
extracellular environment. The urinary bladder is a physically active organ that
undergoes periodic stretching as part of its normal function. In the bladder, abnormal
pressure from a variety of pathologic conditions can result in forces which, over time, can
alter the genetic expression of the proteins of the extracellular matrix. To determine the
role that stretching or mechanical deformation may play in altering the synthetic
phenotype of bladder wall cells, a series of experiments were carried out to quantify
several extracellular matrix messenger ribonucleic acids (mRNAs) and their
corresponding protein levels after mechanical challenge. This report first summarizes the
current knowledge about regulation of cell function by mechanical forces and then
presents data on the effect(s) of mechanical force on several mechanosensitive genes
expressed by human bladder smooth muscle cells (BSMCs).
Using this experimental system, we demonstrated that BSMCs were acutely
sensitive to mechanical deformation and showed alteration of many structural and
extracellular matrix genes. This study demonstrates that BSMC extracellular matrix
secretory phenotype can be altered by the mechanical deformation experienced by these
cells. These data support the concept that deformation of the bladder wall affects the
secretory phenotype of BSMCs and can result in an altered extracellular matrix
composition.
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1. INTRODUCTION:
The purpose of this project is to define, at the molecular level, the process by
which gene expression of the extracellular matrix is regulated by mechanical forces in the
Human Bladder Smooth Muscle cells (BSMCs). The goal is to first localize several
functionally distinct transmembrane proteins; Sarcoglycans (α, β, γ, δ and ε), cytoskeletal
proteins Vimentin, and Desmin to verify their presence in the cultured BSMCs using
fluorescent-labeled antibodies specific for each protein. The sarcoglycans are primarily
responsible for transferring intracellular force generated by the interaction of actin and
myosin while the extracellular proteins are responsible for linking the cells to the
extracellular matrix. These proteins comprise several collagen matrix proteins, e.g., type
I, type III and type IV collagens and an integrin-receptor (11, 64). To evaluate the
functions of these proteins, we will subject the BSMCs, using a cell strain apparatus, to a
level of force which mimics those experienced by the bladder wall during the
filling/emptying cycles. This investigation seeks to find supporting evidence to
determine if altered mechanical stimulation of bladder smooth muscle cells results in an
up-regulation of type III collagen as well as additional genes which mediate the transfer
of intracellular force to the extracellular environment.

1.1 Significance:
The hardening or stiffening seen in diseased tissue is typically associated with an
overproduction of the abundant matrix protein collagen (11) which is the most abundant
protein in the body (24). A challenge to current research is to elucidate the biochemical
steps that initiate an over-accumulation of collagen and associated proteins of the
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extracellular matrix. It is plausible that drugs and other interventions could be used to
stop or slow the process and remove or dramatically decrease the deleterious effects of
the excess matrix that mediate fibrotic disease. Since the collagen genes can be regulated
and influenced by force (7), it is likely that specific steps in the control process can be
targeted either by drugs or other interventions to retard its accumulation (40). Therefore,
the ideal effect of such research would be to define the mechanism by which proteins of
the extracellular matrix are up-regulated causing an overproduction of collagen.
Diseases such as pulmonary, liver, kidney, and bladder fibrosis, systemic sclerosis
and urethral strictures are characterized by the accumulation of excess collagen and other
connective tissue structural macromolecules (5). Specifically, in the bladder wall, the
additional connective tissue can interfere with the normal physiologic operating pressures
of the bladder which, in turn, can be transmitted in a retrograde fashion to the kidneys,
ultimately compromising their function and leading to kidney failure (30). Numerous
studies have documented changes in connective tissue associated with bladder
dysfunction and pathology (2, 30, 63); however, the mechanism by which these changes
are initiated at the cell and molecular levels is currently unknown.

1.2 Background:
Fibrosis, the excessive and persistent formation of scar tissue, is responsible for
morbidity and mortality associated with organ failure in a variety of chronic diseases
affecting the lung, kidney, eyes, heart, liver, bladder, and skin. Fibroproliferative
diseases, including chronic pulmonary, hepatic, renal, vascular, and bladder fibrosis,
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contribute to nearly half of all deaths in 2002 in the USA (34). These disorders
frequently affect multiple organ systems, complicating the elucidation of their underlying
pathogenesis and hindering development of effective treatments.
Many cells and tissues exist in an active mechanical environment and experience
tensional, compressional, pressure-induced, and shearing deformations (61). For
example, lung tissue is stretched during inspiration. Endothelial cells lining the blood
vessels within the body experience shearing deformations owing to the blood flow
against their luminal surfaces (44). The bladder, under normal circumstances, fills with
little or no increase in pressure. When the volume capacity is reached, afferent signals
from stretch receptors trigger the micturition reflex (67). The bladder then empties and a
new filling process begins. In order to accomplish this function, the wall of the bladder
must have mechanical properties which permit it to sustain major volume changes and
strains without showing signs of irreversible changes. Although the type, duration,
intensity, and frequency of these forces may be different at various anatomical sites
throughout the body, cells likely perceive these forces in a similar fashion and convert
them into biochemical signals which alter cell behavior. In the bladder, it is likely that
the mechanical forces regulate cells by activating/deactivating different sets of genes (4).
The process by which a cell is subjected to mechanical force and converts that
force into a biochemical responses is termed mechanotransduction (9). This process is
poorly understood owing to the difficultly in reconstructing force environments to which
cells are normally exposed in vivo; however, it is likely that cells operate optimally
within a range of equilibrium force parameters. If this range were to be exaggerated or
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exceeded, the cell phenotype could change and have pathological consequences resulting
in hypertension, hyperplasia, altered secretion of proteins in an autocrine and/or paracrine
fashion and differential responses to external stimuli and cytokines (43). Compliance (Δ
volume/ Δ pressure), a measure of bladder storage function, has been shown to change in
disease states and during fetal development (32). During fetal development, there is
evidence of active remodeling of the bladder wall (43). Biochemical measurements of
type I and type III collagens show quantitative changes which accompany physiological
changes (58).
Urine storage problems arise when the bladder fails to remain relaxed when filling
causing the bladder to operate at increased pressures which can be transmitted to the
kidneys causing damage and ultimately kidney failure. Abnormal bladder pressure can
be the result of neurogenic factors secondary to stroke, Parkinson’s disease, multiple
sclerosis, or spinal cord injury (28, 46, 53). Physical blockage of the bladder outlet
(obstruction or BPH) can cause the same pressure-related problems. The aging process is
associated with intermittent increases in bladder pressure which can result in involuntary,
non-voiding contractions (bladder overactivity). Regardless of the source of a particular
pathology, when the cellular components of the bladder are subjected to irregular cycles
of filling and emptying, and/or if the velocity (strain rate) at which forces are applied to
the bladder wall is altered as a consequence of overactivity, changes in collagen gene
expression can occur (22).
Collagens are the major structural protein of the body which are encoded by a
family of over 30 genes and which are responsible for its synthesis. These genes respond
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to a variety of signals from both inside and outside the cell (63). Compliance changes
that occur as a consequence of the overproduction of collagen are the fundamental
problem behind fibrotic disorders such as pulmonary fibrosis, cirrhosis, and scleroderma
(14). A thorough understanding of the role of forces in these pathologies and the
biochemical mechanism underlying gene expression will guide treatment and other
therapies to inhibit these diseases.
Based upon prior work and new preliminary data, it has been demonstrated that
collagen gene expression can be manipulated by applying different modes of mechanical
force to cells (3, 10). This information can be used to implement therapies whose goal is
to ameliorate the deleterious effects caused by overproduction of collagen, i.e.,
structurally similar drugs such as mithramycin, mitoxantrone, daunorubicin, and
bisanthracycline, which mimic and interfere with transcription factors binding to their
cognate DNA elements thus preventing their activation (3). If such therapies can be
further refined, they offer novel ways of preventing the harmful effects of excessive
collagen deposition on the normal physiologic functions of tissues and organs. Since
these drugs rely on their molecular structures to mimic the actual transcription factor,
they can only be identified through an understanding of the molecular process by which
gene activation occurs.

1.3 Proposal:
We will test our hypothesis that mechanical stimulation BSMCs results in
increased expression of extracellular matrix genes and genes which mediate force transfer
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intracellularly in BSMCs. Specifically, we will study changes in the expression of 15
genes whose encoded proteins are subdivided into 3 groups: 1); Matrix and matrix
modulatory proteins, 2); Sarcolemma-associated proteins which mediate force transfer,
and 3); Cytoskeletal genes which link sarcolemma associated proteins with actin and
myosin intracellularly. [Expression levels of type III collagen (COL3A1), Connective
Tissue Growth Factor (CTGF), Integrin β-1 (ITGB1), MMP1 and TIMP1 genes were
quantified].

Matrix and Matrix Modulatory Genes
Collagen, the major structural component of the bladder wall, is a family of
proteins which make up approximately 30% of the dry weight of human tissue (1). There
are 26+ different types of collagen with approximately 30+ unique genes, each of which
codes for a specific collagen peptide. The most abundant collagen found in connective
tissue is type I collagen which is a heterotrimetric molecule composed of two α-1
polypeptides [ 1(IV)] and one α-2 polypeptide [ 2(IV)], each of which is the product of
an individual gene; COL1A1 and COL1A2, respectively (48). The polypeptides products
encoded by these unique genes associate with one another to form a rod-like triple helical
molecule that has high tensile strength, is relatively inelastic, and is a major contributor to
the overall mechanical properties of tissues and organs. (16).
Type III collagen is a fibrillar collagen and serves as a major structural
component of the bladder wall. Type III collagen is often associated with type I collagen.
Previous experiments have shown that either type III collagen is minimally regulated
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during development or that there is a highly sensitive post-transcriptional response (8,
50). This suggests that there may be an additional control mechanism which regulates
the levels of type III collagen in the bladder wall. Since previous studies have
demonstrated that type III collagen changes during development and in pathologic states
(50), it is plausible that even small fluctuations in mRNA expression could alter the rate
of synthesis of type III collagen and ultimately influence the collagen fiber composition
of the bladder wall. Changes at the protein level are generally preceded by alterations in
the gene activity of the respective genes that encode for these proteins. Previous studies
have demonstrated that alterations in type III collagen is associated with changes in the
compliance properties of the bladder wall. Thus structural fibers containing type III
collagen play a significant role in tissue stiffening. However, the exact mechanism by
which type III collagen gene expression is up-regulated in unknown.
Collagens play a unique structural role in association with other unique elements
of the bladder wall. Without the appropriate connections between the muscle cells and
other components of the bladder wall extracellular matrix, the ability of the bladder to
empty would be severely compromised. In normal bladders, the composition is
approximately 25% type III collagen and 75% type I collagen (1). In bladders with
progressive fibrotic changes, this ratio shifts to approximately 33% type III collagen and
66% type I collagen (1). Previous experiments support the idea that abnormal cycling
results in progressive fibrosis of the bladder (50). This fibrosis is characterized by
infiltration of some detrusor muscle bundles with increased quantities of type III
collagen.
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CTGF is a matrix-associated protein which, similar to transforming growth factor
beta (TGF-β), can stimulate extracellular matrix production. CTGF also plays a vital role
in extracellular matrix remodeling and wound healing. It is widely accepted that CTGF
promotes the development of fibrosis in collaboration with transforming growth factor
TGF-β (36). As well, it has been implicated in extracellular matrix remodeling, wound
healing, scleroderma, and other fibrotic processes since it is capable of upregulating both
matrix metalloproteases (MMPs) and their inhibitors (TIMPs). Thus, CTGF has the
potential to activate both the synthesis and degradation of the extracellular matrix.
CTGF and TGF-β are ubiquitous mediators of fibrogenesis, although the precise
mechanisms that underlie their concerted effect remain unclear (25). Because TGF-β is a
potent inducer of CTGF, most models postulate that CTGF acts as a downstream
mediator of TGF- β activity, whereas other studies support an independent, rather than
sequential, relationship between the two (20).
CTGF is a multifunctional, cysteine-rich, matrix-associated, heparin binding
protein that is normally expressed at low levels but dramatically enriched in virtually all
fibrotic conditions. In vitro, CTGF mirrors some of the effects of TGF- β on skin
fibroblasts, such as stimulation of extracellular matrix production, chemotaxis,
proliferation, and integrin expression (20). It also regulates multiple processes that
contribute to fibrogenesis, including cell proliferation, migration, adhesion, survival, and
extracellular matrix production.
When an anti-CTGF antibody (FG-3019) is introduced into a system, there is
consistent reduction in the fibrotic response. Thus, the anti-fibrotic activity of the
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antibody, FG-3019, in this model supports a key role for CTGF in mediating fibrogenesis
(41).
Integrins are a large family of membrane receptors, consisting of α-, and βsubunits, which together produce twenty-four distinct heterodimers, and play a pivotal
role in the interaction of cells with the extracellular matrix (29, 42). Integrins serve as the
bridge between the extracellular matrix, the intracellular signaling machinery, and the
actin cytoskeleton. Such interaction regulates the organization of cells in organs and
tissues during development as well as cell differentiation and proliferation (15).
Cells govern tissue shape by exerting highly regulated forces at sites of matrix
adhesion, which is the integrin receptor. Cells shape tissue by pulling on neighboring
cells and extracellular matrices, creating specific levels of tension. In turn, cells are
finely attuned to the forces and rigidity of their surroundings. As rigidity is defined by
the force per unit displacement, rigidity-sensing cells must measure both force and
displacement. As the major force-bearing adhesion-receptor protein, integrins have a
central role in how cells sense and respond to the mechanics of their surroundings (18).
Recent studies have shown that a key aspect of mechanotransduction is the cycle by
which integrins bind to the matrix at the leading cell edge, attach to the cytoskeleton,
transmit mechanical force, aggregate in the plasma membrane as part of increasingly
strengthened adhesion complexes, unbind and, ultimately, are recycled (17). Within this
mechanical cycle, integrins themselves exhibit intramolecular conformational change that
regulates their binding affinity and may also be dependent upon force.
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The integrin mechanical cycle is crucial for cellular function and depends upon
biophysical and biochemical changes in integrin structure post-translational modifications
of integrins and associated proteins. Force likely accelerates integrin activation, both by
extracellular and intracellular rearrangements, induces protein recruitment through
protein stretching, and accelerates integrin clustering leading to deactivation. Dispersal
of adhesion contacts is favored by the loss of tension.
Finally, we will analyze the gene expression of Matrix Metalloproteinase-1
(MMP-1) and Tissue Inhibitor of Metalloproteinases-1 (TIMP-1). These matrixassociated proteins are involved in the breakdown of the extracellular matrix.
Matrix Metalloprotease-1, or MMP-1, is an interstitial collagen protease in
humans which plays a fundamental role in the re-modeling of the extracellular matrix,
specifically type I, type II, and type III collagen (47). In normal physiologic processes,
such as embryonic development, tissue remodeling, and reproduction, matrix
metalloproteases (MMPs) are responsible for the breakdown of the extracellular matrix.
MMPs are a family of twenty-four genes which are organized into six different groups
based on their domain organization and substrate preference (52). These zinc-dependent
endopeptidases also breakdown the extracellular matrix in disease states such as arthritis
and metastasis (52). They are responsible for the degradation of a wide range of
extracellular components and a small number of bioactive molecules, including laminin,
fibronectin, vitronectin, elastin, and proteoglycans (47, 52).
The basic structure of the active form of MMP-1 contains an single peptide which
directs MMP-1 to the secretory or plasma membrane, a domain that maintains
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inactivation of the enzyme by occupying the active site, a zinc-containing catalytic
domain, and a hinge region which links the catalytic domain to the hemopexin-like
domain which mediated interaction with substrates and confers specificity of the enzymes
(52). Activation of MMP-1 following secretion from cells depends on disruption of the
prodomain region with the catalytic site, which may occur by conformation changes of
proteolytic removal of the prodomain (6).
In vivo activity of MMP-1 is highly regulated. It is generally expressed at very
low levels and its transcription is tightly controlled either positively or negatively by
cytokines and growth factors (6). MMP-1 is first secreted as an inactive preprotein and
activated only after a portion is cleaved by extracellular proteinases (38). MMP-1’s
activity is highly regulated by an endogenous inhibitor: Tissue Inhibitor of
Metalloproteinase-1 (TIMP-1) (38). MMP genes with dysfunctional, or absent,
regulation have been implicated in many diseases including arthritis, chronic ulcers, and
cancer (52).
The breakdown of the extracellular matrix is systematic and highly regulated by
tissue inhibitor of matrix metalloprotease (TIMP) activity (52). Four members of the
TIMP family have been characterized, designated as TIMP-1, TIMP-2, TIMP-3, and
TIMP-4. TIMP-1 is a natural inhibitor of matrix metalloprotease-1 (MMP-1),
maintaining the balance between extracellular matrix deposition and degradation in
different physiological processes (21). In addition to its role as an inhibitor of MMP-1,
TIMP-1 is able to promote cell proliferation in a wide range of cell types, and may also
have anti-apoptotic functions and anti- and pro-angiogenc functions (1, 33).
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Normally, TIMP-1 concentrations far exceed the concentration of MMP-1 in
tissue and extracellular fluids. A disturbed balance has been identified in several
pathologic conditions, such as cancer, rheumatoid arthritis, and periodontitis.
Accelerated growth of the extracellular matrix occurs in various pathologic processes,
including inflammation, chronic degenerative diseases, and some tumors (33, 57). In
these cases, TIMP-1 can slow the progression of disease and/or inhibit time growth,
invasion, and metastasis due to their MMP-1 inhibitory activity (65). Thus, transcription
of the TIMP-1 gene is highly regulated and inducible by cytokines and hormones, as well
growth factors that influence MMP-1 expression, i.e., TGF-β and interleukins. In its
soluble form, TIMP-1 is preferentially expressed in epithelial tissue, cartilage, and
muscle (52). The formation of the TIMP-prometalloproteinase complex modulates the
activation of the enzyme.
During mechanical stimulation of the cell, wherein the collagen production is upregulated, we expect to see this collagenase down-regulated. Similarly, TIMP-1 is an
irreversible inactivator of metalloproteinases; specifically MMP-1. If MMP-1 presence
were to decline in the extracellular matrix, we believe the homeostatic process of the cell
would also decrease the relative levels of TIMP-1 through a negative-feedback system.

Sarcolemma-Associated Proteins Which Mediate Force Transfer
The Sarcoglycans (α, β, γ, δ, ε and ζ) are a family of N-glycosylated
transmembrane proteins characterized by a short intra-cellular domain, a single
transmembrane domain, and a large extracellular domain (54). These proteins form a
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complex, the sarcoglycan complex (SGC), which, with other proteins, stabilizes the
muscle cell membrane and mediates transfer of force generated intracellularly to
extracellular matrix components. The SGC is a component of the Dystrophin
Glycoprotein Complex (DGC). A diagram of this complex is shown in Figure 1, and
comprises dystrophin, dystroglycan and the sarcoglycan complex. The DGC is a
membrane-spanning complex that physically links the interior cytoskeleton to the
extracellular matrix in muscle (51). While dystroglycan is found in nearly all cell types,
the sarcoglycan complex is exclusively found in muscle cells.

Figure 1: The dystrophin glycoprotein complex is a
membrane-spanning complex that links the interior
cytoskeleton to the extracellular matrix in muscle cells.
It is critical for muscle integrity. The DGC is composed
of Dystrophin, an elongated cytoskeletal protein that
links to the cytoplasmic γ-actin and the transmembrane
components of the DGC. Dystroglycan is composed of
2 subunits, α and β, each produced from the same gene.
The sarcoglycan complex is composed of multiple
subunits. Mutations in the genes encoding for α-, β-, γ-,
and δ-sarcoglycan can lead to cardiomyopathy and
muscular dystrophy in humans and mice (68).

We will determine if there are changes in the expression of the six subunits of the
sarcoglycans after mechanical stimulation. The transmembrane sarcoglycans are
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associated with the Dystrophin Glycoprotein Complex which is responsible for force
transfer in muscle and are critical to the stability of the muscle fiber membranes as well
as the linking of actin to the extracellular matrix.

Cytoskeletal Genes Which Link Sarcolemma-Associated Proteins with Actin and
Myosin Intracellularly
Desmin, a type III intermediate filament protein, is muscle-specific and is found
associated with the sarcomeres. Desmin filaments are mainly located at the periphery of
Z-disk of striated muscles and at the dense bodies of smooth muscle cells and they have
been postulated to play a critical role in the maintenance of structural and mechanical
integrity of the contractile apparatus in muscle tissues (35). A 52kD protein, desmin
contains three major domains: an α-helix rod, a variable non α-helix head, and a carboxyterminal tail (35). As with all intermediate filaments, desmin is non-polar when
assembled. The rod domain consists of 308 amino acids with parallel α-helical coiled
dimers and three linkers to disrupt it. The rod connects to the head domain. The head
domain contains 84 amino acids with many arginine, serine, and aromatic residues and is
important in filament assembly and dimer-dimer interactions (23). The tail domain is
responsible for integration of filaments and interaction with proteins and organelles (26).
The expression of desmin gene is regulated by a combination of different
transcription control regions in muscle cells. The results from mice deficient in desmin
reveal its fundamental role in cell architecture, force transmission and mitochondrial
function (31). Thus, desmin also plays an important role in muscle cell architecture and
structure since it connects many components of the cytoplasm (45).
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Vimentin is a type III intermediate filament protein expressed in mesenchymal
(stem) cells and is a major cytoskeletal component. In BSMCs it is often used as a
marker of mesenchymally-derived cells or cells undergoing an epithelial-to-mesenchymal
transition during both normal development and metastatic progression (26). Vimentin
plays a significant role in supporting and anchoring the position of the organelles in the
cytosol (26). Vimentin is attached to the nucleus, endoplasmic reticulum, and
mitochondria, and is important in offering flexibility to the cell (15). Vimentin provides
cells with resilience absent from the microtubule or actin filament network, when under
mechanical stress in vivo (59). Therefore, in general, it is accepted that vimentin is the
cytoskeletal component responsible for maintain cell integrity. Additionally, cells
without vimentin are extremely delicate when disturbed with a micropunture (66).
Focal adhesion proteins such as paxillin serve as a point of convergence for
signals resulting from the stimulation of various classes of growth factor receptor. When
integrins interact with the extracellular matrix, they cluster and recruit a wide variety of
intracellular proteins (1). Paxillin, along with talin and vinculin, serves as a focal
adhesion proteome (51). It localizes intracellular surface sites of cell adhesion to the
extracellular matrix at areas called focal adhesions while serving as a scaffold/adapter
protein at the plasma membrane to coordinate interaction between adhesion and growth
factor-derived signals (12). This function results in reorganization of the actin
cytoskeleton at each site.
Focal adhesions form a structural link between the extracellular matrix and the
actin cytoskeleton and are crucial in signal transduction as their components propagate
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signals arising from the activation of integrins following their interaction with
extracellular proteins, such as fibronectin, collagen, and laminin (13). Through the
interactions of its multiple protein-binding modules, many of which are regulated by
phosphorylation, paxillin serves as a platform for the recruitment of numerous regulatory
and structural proteins that control cell adhesion, cytoskeletal reorganization, and gene
expression (12, 13).
Paxillin is a 68 kDa multi-domain signal transduction adapter in specialized actinmembrane-extracellular matrix attachment sites in cultured mammalian cells in vivo (39).
The C-terminal region of paxillin contains four LIM domains that target paxillin to focal
adhesions through, presumably, direct association with the cytoplasmic tail of β-integrin.
The N-terminal region of paxillin is rich in protein-protein interaction sites which are
capable of binding such as tyrosine kinases, such as Src and FAK and other cytoskeletal
proteins such as vinculin and actopaxin, and regulators of actin organization, such as
COOL/PIX and PKL/GIT (39).
Since the cytoskeleton is intimately associated with actin and myosin and the
sarcolemma, we will determine whether cytoskeletal genes that encode Desmin,
Vimentin, and Paxillin proteins are also mechanically regulated by mechanical
stimulation. Desmin, a type III intermediate filament specific to muscle cells, is a critical
linker protein. Vimentin, another type III intermediate filament, functions to anchor the
organelles of the cell and offer flexibility during periods of stress of mechanical forces in
vivo. It is believed that vimentin is the cytoskeletal component responsible for
maintaining cell integrity. Paxillin is a focal adhesion protein which localizes to
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intracellular sarcolemma sites of physical linkage between cytoskeletal proteins and the
extracellular matrix at areas called focal adhesions. (12).
Our rationale for studying expression of the above genes is that their altered
expression would be able to functionally affect bladder physiology. Our hypothesis is
that altered expression of the genes discussed above is a function of the mechanical
forces experienced by BSMCs.
We will test this hypothesis by exposing BSMCs to high strain rate mechanical
stretch and quantify changes in gene expression. Cells will be plated and stretched using
a TensorCell machine developed by E.J. Macarak, Ph.D., which permits the application
of an equibiaxial strain to cultured cells. Total RNA from stretched cells will be
extracted and reverse transcribed to obtain complementary DNA (cDNA). We will
perform Real-Time PCR on the cDNA sample to quantify relative levels of the mRNAs
encoding the genes discussed above whose levels will be compared with identical nonstretched (control) cells. We anticipate certain genes will respond to high strain rate.
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2.0 DETAILED METHODS:
2.1 TensorCell Strain:
E. J. Macarak, Ph.D. has designed and fabricated a device to impart wellcharacterized mechanical forces to BSMCs in vitro. The device is based upon a positive
displacement design in which a circular plate (indenter) comes into contact with a
distensible membrane upon whose upper surface cells are cultured (Figure 2).

Figure 2: TensorCell culture cylinders. TensorCell culture cylinders. The upper plate
contains “adapters” which accept the circular culture cylinders whose lower surfaces are
the distensible membranes. Culture chambers Culture chambers lock into the adapters
and are covered with a threaded cap. The distensible membranes are made of a
transparent silastic material and are coated with rat tail tendon collagen (RTT). The
membranes are stretched across the bottoms of the cylinders and are held in place via an
elastic O-ring. Circular indenters attached to the movable plate engage the silicone
membranes stretching them equibiaxially.

Deformation of a material or a cell that can be related to stresses (forces) is
described as strain. As it relates to this study, cell strain can be simplistically defined as a
change in a linear measurement on the surface of the cell. For example, fluorescent
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beads can be attached to a cell surface and their displacement from one another
measured. The change in linear distance between the beads after application of a
deforming force can be measured as the “stretch ratio” ΔL/L, where ΔL represents the
distance between two points after force application and L represents the original length
distance prior to force. In this study, we utilized 10% strain.
Strain rate is the rate at which the strain is applied to the cell or, simplistically, the
rate at which the line segment between two points is stretched. A strain of 5% can be
applied either over the course of 1 second or 0.1 second. In the latter example, the strain
rate is 10X faster. Deformation can occur in any direction, depending on the way the
force or stress is applied. Equibiaxial strain describes the stretching of the cell uniformly
in all directions simultaneously; as opposed to non-equibiaxial strains, e.g., uniaxial
strains. By placing a pattern of labeled dots on a distensible membrane, the relative
position of the dots can be determined both before and after stretch is applied to the
membrane. Selecting a trio of dots and measuring the distances between the three before
and after stretch, the distances can be used to calculate the changes in length of the two
principal orthogonal vectors. We have demonstrated that the magnitude of these two
vectors is equivalent, meaning the strain is equibiaxial (37).
Small cylinders, across the bottom of which a distensible membrane is attached,
serve as culture cylinder. Cells are plated onto the membrane and allowed to attach
overnight. Once the cells have attached to the membrane, the cylinder is placed in the
upper fixed plate of the apparatus and the top is screwed on, locking it in place. The
whole apparatus is moved into a conventional incubator and incubated at 37°C in a
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humidified atmosphere of 5% CO2 in air. Cables from the encoder enter through a port at
the front of the incubator and connect to the motor. Once the apparatus is positioned in
the incubator, all strain parameters can be controlled externally via a portable computer.
A middle plate which is movable and which has indenter rings attached to it is
located immediately beneath the fixed upper plate. When the indenter rings contact the
underside of the elastic membranes that serve as the bottoms of the culture cylinders, the
membranes are stretched causing them to expand equibiaxially as the indenter rings
moves upward. The degree of expansion is linearly related to the vertical travel of the
indenter and cells attached to the membrane experience a precise equibiaxial strain which
is both quantifiable and reproducible.
The movement of the middle plate is via a geared “slide” whose motion is
controlled by a servo motor. The rotation of the servo motor shaft is translated into a
vertical movement of the middle plate by the geared slide and is controlled by software
instructions that are downloaded into an encoder device that is hardwired to the motor to
control the shaft’s rotation. The pitch on the threads (50/1000 inch/revolution) is known,
so the vertical movement of the indenter per revolution can be calculated and
programmed to control the movement of the middle plate to induce the desired strain.

2.2 Membrane-Matrix Engineering:
Membranes are treated with 2-3 ml of 50 μg/ml Rat-Tail Tendon (RTT) collagen
in 0.5M HAC. The collagen is permitted to dry on the membranes overnight and yields a
hydrophilic membrane to which the BSMCs can adhere.
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2.3 Acquisition and Growth of Bladder Smooth Muscle Cells:
Human bladder smooth muscle cells were derived from pieces of human bladder
tissue normally discarded after ureteral re-implant surgery. Cells were grown in 75 ml2
cell culture flasks in M231 medium (+ Earle’s Salts, L-Glutamine, and 2.2 g/L Sodium
Bicarbonate) containing 10% fetal calf serum, 25 ml of Smooth Muscle Differentiation
Supplement (SMDS) and supplemented with antifungal additives of 0.25 ug/ml
amphotericin B and antibacterial reagents of 100 units/ml BioWhittaker
Penicillin/Streptomycin incubated in a humidified atmosphere of 5% CO2 in air at 37°C.
SMDS is an ionically-based supplement containing fetal bovine serum and heparin. The
addition of SMDS induces differentiation of normal smooth muscle cells.

2.4 Protocol for Subcultivation of Human Bladder Smooth Muscle Cells:
1. When cultures became confluent (~105 cells/cm2), cells were subcultured and
placed into two separate flasks to allow for continued growth and reproduction.
2. The 75 ml2 cell culture flasks were placed in a laminar flood safety cabinet for all
re-feeding and subcultivation procedures.
3. After removal of medium by suction, 10 ml of 0.05% Trypsin-EDTA is added to
the flask and it is placed in the incubator at 5% CO2 in air at 37°C for
approximately 7 minutes. The Trypsin is a serine protease that cleaves cellassociated attachment proteins releasing them from the culture vessel.
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4. When cells have detached from the culture flasks as observed under light
microscopy (~7 minutes), the contents of the flask are suctioned off and placed
into a 15 ml centrifuge tube.
5. The cells are centrifuged for 7 minutes at 1200-1400 rpm to obtain a soft pellet of
BSMCs.
6. The supernatant of Trypsin-EDTA is gently removed from the test tube and the
cells are resuspended in 10 ml of M231 medium (+ Earle’s Salts, L-Glutamine,
and 2.2g/L Sodium Bicarbonate).
7. 5 ml of the resuspended BSMCs are placed into each of two 75ml2 cell culture
flasks and an additional 10 ml of M231 medium is added to each.
8. Both flasks are labeled and returned to the incubator at 5% CO2 in air at 37°C until
confluent.

2.5 Protein Localization/ Identification:
Human bladder smooth muscle cells were cultured and plated in separate collagen-coated
plates at 5% CO2 in air at 37°C. Cells were grown for 2-4 days or until confluent.
1. When cells were confluent, medium is suctioned out of wells and cells washed
with cold PBS 3x.
2. After the final PBS rinse, cells were fixed with 4% Formaldehyde.
3. After 15 minutes fixation at room temperature, cells were washed with cold PBS
3x before adding 0.1% Triton solution to the cells.
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4. After 15 minutes in room temperature, cells were washed with cold PBS 3x
before adding 30 µl of the selected primary mouse antibody to the experimental
slides. The antibodies used in our experiment were specific for Sarcoglycans (α,
β, γ, δ and ε; 1:50) Vimentin (1:300 dilution in PBS), Desmin (1:50 dilution in
PBS), and type IV collagen (1:50 dilution in PBS).
5. Cells were covered and incubated at 4°C for 1-2 days.
6. After incubation with primary antibody, cells were washed with cold PBS 3x.
7. 30 µl of the fluorescent-labeled secondary antibody was added to the slides.
8. Cells were incubated at room temperature for 1-2 hours.
9. Cells were washed with cold PBS 3x and coverslipped and sealed with a clear nail
polish.
10. Slides were examined with a Zeiss microscope equipped with epifluorescence
optics and a digital camera.
11. For controls, primary antibodies were omitted.

2.6 Human Bladder Smooth Muscle Plating to TensorCell Wells:
TensorCell wells were washed in detergent in a SONOGEN Ultrasound bath before
being rinsed thoroughly in deionized water and sterilized in 70% ethanol for 24 hours.
Wells were removed from the ethanol and dried overnight on a sterile surface in the
laminar flow hood. Membranes were then coated with RTT collagen as described above.
1. Confluent cultures of cells growing in T-75 flasks were trypsinized and counted in
NucleoCounter to obtain cell count per ml.
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2. After centrifugation and re-suspension of the cell pellet, an equal number of cells,
based upon the NucleoCounter data were added to each well. Cells plated at
confluent density.
3. The wells were placed in covered petri dishes, and placed petri dishes in sealed
plastic bags to prevent contamination and incubated overnight at 37°C in a
humidified atmosphere of 5.0% CO2 in air.

2.7 Application of Strain to Human Bladder Smooth Muscle Cells:
1. Confluent wells were placed on the apparatus and the program downloaded.
2. Cells were stretched at 10% strain (20 cycles/min) for 7-8 hours in TensorCell
machine while incubated at 37°C in a humidified atmosphere of 5.0% CO2 in air.
3. Control cells remain unstretched and incubated under identical conditions.

2.8 Purification of Total RNA from Human Bladder Smooth Muscle Cells:
After stretching, wells were removed and washed with clod PBS 3x. 1 ml of 0.05%
Trypsin-EDTA was added to each well and it was placed in the incubator at 5% CO2 in
air at 37°C. After cells have detached from the silicone membrane, 1 ml of M231
medium was added to neutralize the trypsin/EDTA and the cells were collected by
centrifugation for 7 minutes at 1200-1400 rpm in sterile tubes and counted using the
NucleoCounter to obtain an accurate cell count per ml.
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1. The supernatant was removed from the test tubes and Buffer RLT/ β –ME (see
Table 1) was added. Cells were immediately disrupted and homogenized.
Disrupted cells were pipetted into QIAGEN QIA Shredder Mini Spin Columns.

Table 1: Volumes of Buffer RLT to Tissue Disruption and Homogenization

Amount of starting material (mg)

Volume of Buffer RLT (µl)

<20

350 or 600*

20-30

600

*Use 600 µl Buffer RLT for tissue stabilized in RNAlater RNA Stabilizing or for difficult-to-lyse tissues.

2. The lysates were centrifuged for 2 min at 14000 rpm. The filter was removed
from the spin column and 1 volume of 70% ethanol was added to the cleared
lysate, and mixed immediately by pipetting.
3. Samples were transferred into a QIAGEN RNeasy Mini Spin Colum and placed in
a 2 ml collection tube and centrifuged for 15s at 14000 rpm. The flow-through
was discarded.
4. 700 µl Buffer RW1 was added to the RNeasy Spin Column and centrifuge for 15
s at 14000 rpm to wash the Spin Column membrane after which the flow-through
was discarded.
5. The column membrane was washed 3x with 500 µl of Buffer RPE followed by
centrifugation for 15 s at 14000 rpm.
6. The RNeasy Spin Column was placed in a new 1.5 ml collection tube and 30-50
µl RNase-free water added directly to the Spin Column membrane. The samples
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were allowed to sit at room temperature for 5 mins followed by centrifugation for
1 min at 14000 rpm to elute the RNA from the membrane.
7. The total RNA was quantified by Optical Density (OD) measurements and its
quality was assessed by 2% agarose gel electrophoresis as seen in Figure 3.

Figure 3: The 28S and 18S rRNA subunits in the control
and experimental samples show that the extracted RNA
was intact.

8. Collected RNA was stored at -80°C.
2.9 Reverse Transcription (RT) of total RNA from Human Bladder Smooth Muscle
Cells
to Compliment DNA (cDNA):
Reverse transcription of RNA-to-cDNA was accomplished via a High Capacity
RNA-to-cDNA kit purchased from Applied Biosystems. Components of this kit
(4387406) include 500 µl of 2X RT Buffer Mix and 50 µl of 20X RT Enzyme Mix.
1. Kit components were allowed to thaw on ice.
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2. The volume of reagents needed was calculated as shown below in Table 2. Some
additional reactions were included in the calculations to provide excess volume
for the loss that occurs during reagent transfer.
Table 2: Volumes of kit components used for each experiment.

Component

Volume/Reaction (µl)

2X RT Buffer
20X RT Enzyme Mix
Nuclease-free H2O
Sample
Total per Reaction

10
1
*Q.S. to 20 µl
up to 9 µl
20

*Q.S. Quantity Sufficient

3. Reagents were gently mixed and placed on ice.
4. The thermal cycler was programmed according to the manufacturer’s instructions
as shown below in Table 3.
Table 3: These conditions are optimized for use
with the High Capacity RNA-to-cDNA Kit.
Step 1

Step 2

Step 3

Temperature

37

95

4

Time

60 min

5 min

∞

5. Set the reaction volume to 20 µl.
6. Load the reactions into the thermal cycler and start the reaction.

2.10 Quantitative Real-Time Polymerase Chain Reaction (PCR) of cDNA:
RT-PCR analysis was performed using the Applied Biosystems 7300 PCR
machine in conjunction with Sequence Detection Software (SDS) v3.1. Samples were
loaded into a TaqMan 96-well plate containing a custom format (PN 4413261) of primer
signatures for 14 experimental genes along with 2 control reagents. The TaqMan Gene
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Expression Assays evaluate the yield of cDNA conversion through quantitative PCR
analysis. Each of the plates, shown in Figure 4, contains six replicates of manufacturing
control (18S rRNA) and 15 gene expression primer sets corresponding to the following
genes: HPRT (control), type III collagen (COL3A1), connective tissue growth factor
(CTGF), desmin (DES), vimentin (VIM), paxillin (PXN), β-1 integrins (ITGB1), matrix
metalloprotease-1 (MMP1), tissue inhibitor of MMP1 (TIMP1), α-, β-, γ-, δ-, ε-, and zsarcoglycans (SGCA, SGCB, SGCD, SGCG, SGCE, SGCZ).

Figure 4: TaqMan 96-well custom plates containing six
replicates of manufacturing control (MC) and 15
experimental assays.

Plates were loaded as described below.
1. 500 µl of Nuclease-free H2O, 495 µl of TaqMan Master Mix, and 5 µl of RT
reaction mix was combined into a 1.5 ml sterile sample test tube.
2. After mixing gently and thoroughly, 20 µl of reaction mix was aliquotted into
each well of 96-well plate before plate was sealed.
3. Plate was briefly centrifuged to spin down the contents and to eliminate air
bubbles.
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4. The thermal cycling conditions for the plate were specified based on the
manufacturer’s instructions.
5. The specific detectors were loaded into the SDS software and the appropriate
genes were labeled as endogenous controls.
6. When finished, data was observed and analyzed before exporting to an excel
spreadsheet.
7. Once exported, the relative fold change of each gene compared to its respective
control was analyzed.

For the purpose of comparison between samples, an average of every control is taken
as a calibrator. Comparisons of the gene of interest mRNA levels between experimental
treatments are performed by ΔΔCt analysis according to the following formulas:

Ct(gene of interest) – Ct(housekeeping gene) = ΔCt
ΔCt(experimental gene of interest) – ΔCt(calibrator gene of interest) = ΔΔCt

Assuming 100% efficiency, each cycle in an RT-PCR represents a doubling of
double-stranded DNA (dsDNA). From this assumption, the fold-change in expression for
each gene of interest’s mRNA level versus the calibrator gene of interest’s mRNA level
was determined according to the following formula:
Fold Change(gene of interest) = 2^(- ΔΔCt)(gene of interest)
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3.0 EXPERIMENTAL EVALUATION:
3.1 Immunolocalization of stretch-associated proteins in Human Bladder Smooth
Muscle cells:

Control BSMCs were first cultured and plated in separate collagen-coated plates.
Fluorescent-labeled antibodies were used to localize and identify several functional
distinct proteins of study associated with the force transfer within the cell.
Immunohistochemistry analysis, seen in Figures 5, 6, 7, and 8, demonstrate the presence
of these proteins in our control cells.

Figure 5: The immunofluorescent analysis of type [III]
collagen (B; green) and β–sarcoglycans (A; red) demonstrate
their co-localized positions in the cell.

Figure 6: Immunohistochemistry characterizing the
presence of (clockwise) α-sarc, β-sarc, γ-sarc, and δsarc in the human bladder smooth muscle cells.
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Figure 7: Immunofluorescent staining displays the
location of desmin filaments in bladder cells. Desmin
filaments form around the dense bodies of smooth
muscle cells and play a critical role in the maintenance
of structural and mechanical integrity of the contractile
apparatus in muscle tissue.

Figure 8: Immunohistochemistry used to determine
the existence of vimentin in BSMCs. Vimentin
filaments play a critical role in the positioning and
stabilization of the muscle cell during contraction and
excessive trauma to the sarcolemma.

3.2 Quantitative RT-PCR Analysis:
Analysis was carried out on 23 samples of stretched cells and 5 samples of
unstretched cells. The average concentration of RNA among the stretched samples was
127.7 ng/µl, with a range of 4.8 ng/µl to 343.5 ng/µl. From these samples we reverse
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transcribed the four with the highest relative concentration of RNA, between 250-350
ng/µl, and compared them against their associated controls, as seen in Figure 9.

RNA Concentration (ng/ul)

RNA Concentration
400
350
300
250
200
150
100
50
0
1

2

3

4

HBSmM Sample

Figure 9: Four samples were selected for RT-PCR
analysis based on their concentration of RNA.

After RT-PCR was performed and analyzed, the relative fold change of each gene
was compared to its control. Fold change is a metric for comparing a gene’s mRNA
expression level between two distinct conditions. The fold change of all four samples
was imported into a spreadsheet and analyzed using a paired t-test to determine the
statistical significance of each. Graphical representations of the results are shown below
in figures 10-23. All comparisons are between the levels of gene expression of stretched
cells versus unstretched controls. Extracellular matrix genes type III collagen
(COL3A1), connective tissue growth factor (CTGF) and matrix receptor β-integrin all
showed increased expression. Matrix metalloprotease-1 (MMP-1) gene expression
decreased as did its specific inhibitor TIMP-1. Cytoskeletal genes paxillin (PXN) and
desmin (DES) both did not change significantly while a third cytoskeletal protein,
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vimentin (VIM), increased its expression as a function of stretch. Within the sarcoglycan
group, α, β, δ and ζ increased in expression while γ decreased and ε showed no change.
*represents statistical significance (p < 0.05)

Figure 10: Quantitative PCR Analysis
of α-1 [III] Collagen

Figure 11: Quantitative PCR Analysis
of Connective Tissue Growth Factor

Type III collagen and CTGF showed significant up-regulation of gene expression
in the stretched sample (p= 0.0046 and 0.0269, respectively) when compared to their
unstretched control sample.
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Figure 12: Quantitative PCR Analysis
of Integrin β-1

Figure 13: Quantitative PCR Analysis
of Paxillin

Integrin β-1 gene expression was up-regulated to a statistically significant level
after stretch application (p= 0.0305), but cytoskeletal protein paxillin did not show any
significant change (p= 0.3181).

Figure 14: Quantitative PCR Analysis
of Desmin

Figure 15: Quantitative PCR Analysis
of Vimentin

Cytoskeletal protein desmin gene expression did not rise to a statistically
significant level after the application of stretch (p= 0.0605), but vimentin showed a
significant up-regulation during the same experiment (p= 0.0484).
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Figure 16: Quantitative PCR Analysis
of Matrix Metalloprotease-1

Figure 17: Quantitative PCR Analysis
Tissue Inhibitor of Metalloprotease-1

Matrix-associated genes MMP-1 and TIMP-1 showed a significant change in
expression after stretch. MMP-1 gene expression was effectively eliminated (p= 0.0001)
while its inhibitor, TIMP-1, was also down-regulated (p= 0.0068).

Figure 18: Quantitative PCR Analysis
of α-sarcoglycans

Figure 19: Quantitative PCR Analysis
of β-sarcoglycans

α-, and β-sarcoglycan gene expression increased to a statistically significant level
after stretch application (p= 0.0462 and p=0.0263, respectively).
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Figure 20: Quantitative PCR Analysis
of δ-sarcoglycans

Figure 21: Quantitative PCR Analysis
of ε-sarcoglycans

δ- sarcoglycan gene expression up-regulated significantly after stretch (p=
0.0053), but ε-sarcoglycan failed to show any significant alteration as a result of the
stretch application (p= 0.0596).

Figure 22: Quantitative PCR Analysis
of γ-sarcoglycans

Figure 23: Quantitative PCR Analysis
of ζ-sarcoglycans

γ-sarcoglycan gene expression was down-regulated significantly after stretch (p=
0.0002), in contrast to all other transmembrane sarcoglycan proteins while ζ-sarcoglycan
up-regulated significantly (p= 0.0100).
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3.3 Discussion:
It is known that the bladder wall undergoes profound remodeling resulting from
pathologies such as spinal cord injury or obstruction, but there have been few studies
examining the role of strain in the remodeling process (46, 50, 53). This research has
attempted to study the effect of strain on human bladder smooth muscle cell gene
expression in vitro, and has shown that strain is capable of inducing profound changes in
a group of genes chosen for study because of their involvement in the transfer of force
from within the muscle cell to the extracellular matrix. Type III collagen was chosen
because it is a major structural protein found in association with the bladder smooth
muscle cell in vivo. CTGF gene expression is involved with the control of matrix gene
expression for genes like type III collagen, while MMPs and TIMPs exert control over
matrix degradation. Vimentin, paxillin and desmin are all cytoskeletal proteins which
have been implicated in transfer of actin-myosin-generated force in muscle cells to the
extracellular matrix. The sarcoglycans are important transmembrane components of the
DGC and represent physical linkages between cytoskeletal components and the
extracellular matrix. Finally, β-integrin is an important matrix receptor which has been
implicated in cell attachment and adhesion and, therefore, could theoretically be
implicated in force transfer together with the sarcoglycans.
The strain parameters chosen mimic some of the physical conditions experienced
by patients with uncontrolled and non-voiding contractions of the bladder wall. These
types of contractions occur at high strain rate and occur in a variety of pathologies
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including those which result as a consequence of normal aging. Our data support the
view that high strain rate forces can alter gene expression in BSMCs.
In fibrotic tissues, collagen gene expression is altered. In previous studies of
patients with either neurogenic or obstructive uropathies, the concentration of type III
collagen increased from 25% to 33% in bladders with progressive fibrotic changes (1).
Our data shows that type III collagen gene expression is up-regulated as a consequence of
the application of 10% strain on BSMCs for 7 hours. Previous experiments support the
concept that abnormal cycling can result in progressive fibrosis of the bladder (50). This
fibrosis is characterized by infiltration of some detrusor muscle bundles with increased
quantities of type III collagen. In the study presented here, we have attempted to mimic
the conditions found in humans whose bladders sustain uncontrolled, intermittent, nonvoiding contractions. These types of contractions can be classified as high strain
contractions since they occur at high frequency over a short period of time. Normal
bladder muscle tissue contracts maximally only during voiding, approximately 6 times
per day. In our experiments, we have used a strain level of 10% and frequency of
20/minute to mimic high strain rate contractions. As a consequence of the force
parameters used in these studies, major changes in gene expression occurred suggesting
that mechanical strain plays a major role in regulating a number of genes encoding
proteins involved in extracellular matrix homeostasis and force transfer within bladder
smooth muscle cells.
CTGF plays a critical role in pathogenesis by promoting collagen synthesis and
deposition. Similarly, CTGF appears to be regulated by mechanical force and likely
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contributes to the fibrotic process found in tissues through its regulation by TGF-β. In
this study, we found the concentration of CTGF mRNA to be significantly increased after
exposure to mechanical force. CTGF, like collagen type III, appears to play a critical role
in maintaining the steady-state level of matrix macromolecules. CTGF expression can be
regulated by TGF-β (36). It is possible that TGF-β can manifest changes to the
extracellular environment through its direct or indirect activation of type III collagen and
CTGF.
TGF-β is a multifunctional cytokine that has been shown to induce new matrix
synthesis. Intracellular signaling mediated by TGF-β has been shown to up-regulate
collagen synthesis by mechanical stretch in other cell types, including smooth muscle
cells (20, 25). In addition, neutralizing the TGF-β activity with anti- TGF-β antibody
ablated stretch-induced up-regulation of collagen mRNA expression (36). Although we
did not specifically evaluate changes in TGF- β, previous result are consistent with the
view that TGF-β up-regulation by mechanical stretch stimulates gene expression of type
III collagen and that up-regulation is mediated by CTGF.
Matrix metalloproteases play a critical role in the remodeling of extracellular
matrix. Our findings suggest that mechanical strain does not induce MMP-1 synthesis,
but rather suppresses it. This data supports the view that mechanical deformation can
dramatically affect the expression of genes encoding an enzyme that plays an important
role in the architecture and organization of the extracellular matrix. One of the
physiological characteristics of many types of bladder uropathies is increased deposition
of collagen resulting in decreased bladder compliance. If there is decreased degradation
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and increased synthesis of collagen in the bladder wall, the result will be an overall
increase in the level of collagen in the bladder wall. This would appear to be the case
when the cells are subjected to an increased mechanical force. Overall, the data
presented here show that there is an increase in gene expression of type III collagen and a
decrease in expression of MMP which theoretically would result in an overall increase in
type III collagen.
The enzymatic activity of MMPs is regulated at several levels, specifically by
their endogenous inhibitors, TIMPs. TIMP-1 is a low, tight-binding inhibitor of MMP-1
collagenase. Thus, it is logical that the expression of MMPs and TIMPs should be
inversely proportional. Our results show that as levels of MMP-1 decrease, TIMP-1
concentrations fall suggesting that TIMP expression mimics that of MMP expression.
This would suggest that it is disadvantageous to the cell to produce more TIMP-1
than is necessarily required at any time. As an irreversible inhibitor, TIMP-1’s inhibition
of MMP-1 occurs on a 1:1 scale. Thus, a cell would only require enough TIMP-1 to
mitigate the enzymatic activity of MMP-1 and its levels should approximate those of the
MMP whose activity it inhibits. Our data shows that MMP-1 activity if effectively
eliminated in response to the forces applied during our experiments and that a similar
change in TIMP expression also occurs perhaps via a negative-feedback system.
Integrins bind specific amino acid sequences found in extracellular matrix
proteins. By virtue of its direct physical attachments to the matrix, cell surface integrins
are able to respond to environmental forces thus making it a potential
mechanotransducer. Our studies demonstrate that after a period of applied strain, the
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bladder cells significantly up-regulated their transcription of integrin mRNA to a
statistically significant level. Integrins may act, in muscle tissue, as an extra mechanism
for force transfer both inside-to-outside and outside-to-inside. Integrin-based cell matrix
binding may strengthen or reinforce other types of force transfer mechanisms such as
those associated with the DGC. Increases in integrin expression occur rapidly and may
be crucial to protect the cell from over stretching the DGC. Our laboratory has
previously demonstrated an increase in adherens-based junctions in bladder smooth
muscle from obstructed animals suggesting that these types of structures may help
compensate for the increased force demands placed on the DGC which have been
suggested to be less robust physically than integrin-based binding (68). Further studies of
mechanical strain in which the time frame of applied force is varied could be used to
determine if the cell increases its relative level of integrin receptor proportional to the
levels of force applied.
The gene expression of several cytoskeletal proteins was also quantified. Paxillin
serves as a scaffold/adapter protein at the plasma membrane. Through the interactions of
its multiple protein-binding modules paxillin serves as a platform for the recruitment of
numerous regulatory and structural proteins that control cell adhesion, cytoskeletal
reorganization, and gene expression (12, 13). Although paxillin is an important
cytoskeletal protein, it does is not appear to play a significant role in the response of
BSMCs to force since there was no significant change in paxillin concentration. The
same is true of muscle-specific intermediate filament protein desmin whose expression
was also unchanged. This would suggest that the steady-state level of desmin mRNA is
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sufficient to maintain the cells level of this protein, even during periods of increased
force demands on the smooth muscle cell.
Vimentin is the only cytoskeletal protein studied whose expression increases
significantly. Prior studies support the view that vimentin is especially critical in
anchoring organelles to the cytoskeleton and offering flexibility to the cell during periods
of mechanical stress forces and, thus, it’s up-regulation may be involved with the overall
process of how a cell responds structurally to an active physical environment in vivo (15,
66).
All sarcoglycan complex component mRNAs except ε showed altered gene
expression. With the exception of γ, all sarcoglycans showed increased expression. This
supports the view that the sarcoglycan transmembrane proteins function to stabilize the
sarcolemma during periods of stress and/or normal transfer of intracellularly generated
force to the extracellular matrix. The sarcoglycan transmembrane complex functions in
connecting the muscle fiber cytoskeleton to the extracellular matrix effectively
transferring actin-myosin induced force across the sarcolemma preventing damage to the
fiber (54). Thus, the sarcoglycans are critical components which help the cell
communicate with and monitor levels of force generated during normal cell activity.
Their up-regulation is consistent with the view that a cell that is challenged mechanically
must physically up-regulate those structures required to carry out force transfer. The γsarcoglycan subunit (SGCG) concentration decreased considerably after the cells were
subjected to high strain rate. This statistically significant decrease in concentration is in
contrast to the results seen among all other sarcoglycan subunits except ε which showed
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no change. One possible explanation for this can be derived from research performed by
Tewari, et al. (62). Their studies, involving skeletal muscle cells, found evidence to
support the view that δ-sarcoglycan function is associated with cell rigidity. Mice
deficient in SGCG exhibited an increased contractile response that resulted in greater
shortening and widening of the sarcolemma. The researchers concluded that SGCG
normally moderates contractile stress in skeletal muscle. It is possible that SGCG plays a
similar role in smooth muscle and the drastic decrease in concentration is a natural
response to mechanical forces to permit the sarcoglycan complex to be more flexible.
Taken together, these results suggest that BSMCs respond to stretch by upregulating a number of genes responsible for force transfer across the sarcolemma
including the sarcoglycans, β-integrin and the cytoskeletal protein vimentin. In addition,
there is a very significant and substantial up-regulation of type III collagen and CTGF
whose combined activities can lead to a major change in the composition of the
extracellular matrix.
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